Ishita Drugs & Indus Share Price | Ishita Drugs & Indus Stock Screener
ISHITADR
Pharmaceuticals
Share Price BSE
₹73.10
▼
-1.31 (-1.76%)
As of July 3, 2026, the Ishita Drugs & Indus share price (BSE: ISHITADR) is ₹73.10, down 1.76% from the previous close, with shares trading between ₹73.00 and ₹75.00, and a 52-week range of ₹67.60–₹84.00.
Analyse ISHITADR share price data and track historical price performance.
Use the Ishita Drugs & Indus stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Ishita Drugs & Indus Market Cap
₹22.80 Cr.
ISHITADR P/E Ratio (TTM)
29.28
Ishita Drugs & Indus P/B Ratio
1.97
EPS (TTM)
₹2.60
Dividend Yield
-
Debt to Equity
0.19
ISHITADR 52 Week High
₹84.00
Ishita Drugs & Indus 52 Week Low
₹67.60
Operating Margin
5.00%
Profit Margin
6.67%
ISHITADR Revenue (TTM)
₹15.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹16.00
Total Equity
₹11.00
Ishita Drugs & Indus Share Price Chart
Screen Ishita Drugs & Indus share price with an interactive chart. Analyse ISHITADR price trends and volatility across different timeframes.
Ishita Drugs & Indus Company Profile - Fundamental Screener
Screen Ishita Drugs & Indus company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ISHITADR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE806D01016
Ishita Drugs & Indus Balance Sheet Screener
Screen ISHITADR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 16 | 11 | 11 | 11 | 9 | 10 | 8 | 7 | 7 | 8 |
| Current Assets | 15 | 10 | 10 | 10 | 8 | 8 | 7 | 6 | 6 | 7 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 11 | 10 | 9 | 9 | 8 | 7 | 6 | 6 | 6 | 6 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 8 | 7 | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 3 |
Ishita Drugs & Indus Income Statement Screener - Profit & Revenue Analysis
Screen Ishita Drugs & Indus income statement and profit fundamentals.
Analyze ISHITADR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Ishita Drugs & Indus share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15 | 15 | 16 | 12 | 14 | 14 | 15 | 9 | 7 | 7 | 7 | 8 |
| Expenses | 14 | 14 | 14 | 11 | 13 | 13 | 14 | 9 | 6 | 6 | 7 | 7 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
| Operating Profit % | 5.00% | 7.00% | 6.00% | 6.00% | 8.00% | 7.00% | 5.00% | 6.00% | 7.00% | 6.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS | 2.60 | 2.90 | 2.50 | 1.93 | 2.69 | 2.77 | 1.83 | 1.18 | 0.83 | 0.61 | 0.46 | 0.74 |
Ishita Drugs & Indus Cash Flow Screener - Liquidity Fundamentals
Screen ISHITADR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -4 | 2 | -3 | 3 | -1 | 1 | 1 | 1 | 1 | 0 |
| Investing Activities | -1 | 0 | 1 | -1 | 3 | -1 | -1 | -1 | -1 | 0 |
| Financing Activities | 4 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | -1 | 1 |
| Net Cash Flow | 0 | 1 | -1 | 2 | 2 | 0 | 0 | 0 | -1 | 1 |
Ishita Drugs & Indus Shareholding Pattern Screener
See Ishita Drugs & Indus shareholding pattern with promoter, FII, and DII holdings.
Check Ishita Drugs & Indus promoter holding and ownership changes for ISHITADR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.04% | 49.91% | 49.92% | 49.96% | 50.04% | 49.42% | 49.80% | 49.80% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 47.37% | 46.89% | 46.76% | 46.63% | 46.33% | 47.48% | 47.51% | 47.17% |
| Other Holding | 2.60% | 3.20% | 3.33% | 3.42% | 3.63% | 3.09% | 2.69% | 3.03% |
| Shareholder Count | 5,194 | 5,398 | 5,341 | 5,320 | 5,263 | 5,351 | 5,272 | 5,555 |
Ishita Drugs & Indus Share Dividend Screener - Share Yield Analysis
Check Ishita Drugs & Indus dividend history with payout and yield data.
View Ishita Drugs & Indus dividend details including ex-dates and amounts for ISHITADR stock.
Ishita Drugs & Indus Stock Index Membership
See which indices include Ishita Drugs & Indus stock.
Check ISHITADR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Ishita Drugs & Indus Market Events Screener - Corporate Actions
Get Ishita Drugs & Indus corporate actions including splits, bonuses, and buybacks.
Check Ishita Drugs & Indus stock events that may affect ISHITADR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 8.66% | ||
| Annual General Meeting | NA | -3.22% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -2.87% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 6.73% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -0.40% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -9.29% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -2.94% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.35% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 1.31% |
Ishita Drugs & Indus Competitors Screener - Peer Comparison
Screen ISHITADR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 446,636 | 38.82 | 58,220 | 6.38% | 11,565 | 62.37 |
| Divis Laboratories | 177,864 | 69.38 | 10,560 | 8.73% | 2,520 | 52.31 |
| Torrent Pharmaceuticals | 152,971 | 71.51 | 13,886 | 20.34% | 2,138 | 56.90 |
| Cipla | 116,256 | 30.13 | 29,045 | 2.24% | 3,870 | 65.46 |
| Dr Reddys Laboratories | 112,635 | 27.10 | 33,593 | -0.44% | 3,998 | 69.37 |
| Zydus Life Science | 110,887 | 21.63 | 26,720 | 13.65% | 5,242 | 61.62 |
| Lupin | 107,337 | 20.00 | 27,488 | 19.98% | 5,345 | 58.20 |
| Mankind Pharma | 101,633 | 52.44 | 14,278 | 12.03% | 1,750 | 57.08 |
| Aurobindo Pharma | 90,291 | 25.78 | 33,385 | 3.21% | 3,376 | 67.06 |
| Laurus Labs | 78,447 | 88.02 | 6,868 | 22.01% | 890 | 64.65 |
Ishita Drugs & Indus Company Announcements - News Screener
Screen ISHITADR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-04 | Closure of Trading Window | - |
| 2026-07-01 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | - |
| 2026-06-26 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | - |
| 2026-05-30 | Outcome Of Board Meeting Held On 30Th May 2026 | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2026 | - |
| 2026-05-23 | Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-23 | Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2026 | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-22 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-13 | Non Applicability Of Regulation 32(1) Of SEBI(LODR) Regulations 2015 | - |
| 2026-04-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-02-27 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 | - |
| 2026-02-24 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 | - |
| 2026-02-19 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 | - |
| 2026-02-14 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 | - |
| 2026-02-07 | Outcome Of Board Meeting Held On 07Th February 2026 | - |
| 2026-02-07 | Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th February 2026 | - |
| 2026-01-30 | Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 2025 | - |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |